Market Research Future published a research report Global Paroxysmal Supraventricular Tachycardia (PSVT) Market and Forecast of Global Market 2018. The report begins with the overview of Industry structure, and describes industry environment, then analyses market size, share and forecast.
Pune, India -- (SBWIRE) -- 06/21/2018 -- The Global Paroxysmal Supraventricular Tachycardia (PSVT) Market is expected to register a CAGR of approximately 6.50% during the forecast period, 2017–2023.
Supraventricular tachycardia is a condition where there is a rapid increase in the heart rate that is caused by electrical impulses originating above the heart. Paroxysmal supraventricular tachycardia, also known as PSVT, is a condition wherein the patient shows an irregularity in heart beating. People suffering from this disorder experience sudden and unexpected occurrence of rapid heart rate that start and stop without warning. A normal heart beats between 60 to 100 beats per minute, but the heart rate of a person suffering from paroxysmal supraventricular tachycardia during an episode may exceed 150–200 beats per minute.
The prevalence of Paroxysmal Supraventricular Tachycardia (PSVT) is unknown but is projected to be around several cases per thousand persons. But, a recent study conducted by Milestone Pharmaceuticals suggested that about 1.7 million patients in the U.S. were suffering from paroxysmal supraventricular tachycardia since the last five years.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/5918 .
Key Players for Global Paroxysmal Supraventricular Tachycardia (PSVT) Market
Some of the key players in the Global Paroxysmal Supraventricular Tachycardia (PSVT) Market are GlaxoSmithKline PLC (U.K.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), AstraZeneca PLC (U.K.), Teva pharmaceutical industries (Israel), Sanofi SA (France), Medtronic, Inc. (U.S.), Glenmark Pharmaceuticals (U.S.), St. Jude Medical, Inc. (U.S.), BIOTRONIK SE & Co. KG (U.S.), GE Healthcare (U.S.), Boston Scientific Corporation (U.S.), Abbott Laboratories Inc. (U.S.), (Alcon) Novartis (U.S.), Siemens AG (Germany), Koninklijke Philips N.V. (U.S.), and others.
Regional Analysis for Global Paroxysmal Supraventricular Tachycardia (PSVT) Market
The Global Paroxysmal Supraventricular Tachycardia (PSVT) Market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas region dominates the Global Paroxysmal Supraventricular Tachycardia (PSVT) Market. Besides, the occurrence of Supraventricular Tachycardia (SVT) is approximately 35 cases per 100,000 patients with a prevalence of 2.25 cases per 1,000 among the American population.
The European market is expected to hold the second largest market share for the Global Paroxysmal Supraventricular Tachycardia (PSVT) Market over the forecast period. Norway and Sweden are among the key countries within the European Paroxysmal Supraventricular Tachycardia (PSVT) Market. The subtypes atrial tachycardia and Atrioventricular Reentrant Tachycardia (AVRT) account for approximately 10% and 30% of the SVT cases, respectively.
The Asia Pacific region is emerging at the highest growth rate than any other region Globally. In the region, countries such as China and Japan are exhibiting high occurrence rate for heart disorders. The increasing demand for diagnostic outpatient surgeries has fueled the growth of the Paroxysmal Supraventricular Tachycardia (PSVT) Market in Asia Pacific. In India, the increasing healthcare services, availability of low cost of labor, increasing number of hospitals, and better access to technology drive the growth of this market.
Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/5918 .
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
TOC Continued…
LIST OF TABLES
Table 1 Paroxysmal Supraventricular Tachycardia (PSVT) Industry Synopsis, 2017–2023
Table 2 Paroxysmal Supraventricular Tachycardia (PSVT) Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Paroxysmal Supraventricular Tachycardia (PSVT) Market, By Region, 2017–2023, (USD Million)
Table 4 Paroxysmal Supraventricular Tachycardia (PSVT) Market, By Type, 2017–2023, (USD Million)
Table 5 Paroxysmal Supraventricular Tachycardia (PSVT) Market, By Diagnosis, 2017–2023, (USD Million)
Table 6 Paroxysmal Supraventricular Tachycardia (PSVT) Market, By Treatment, 2017–2023, (USD Million)
Table 7 North America Paroxysmal Supraventricular Tachycardia (PSVT) Market, By Type, 2017–2023, (USD Million)
Continued…
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Paroxysmal Supraventricular Tachycardia (PSVT) Market
Figure 3 Segmentation Market Dynamics For Paroxysmal Supraventricular Tachycardia (PSVT) Market
Figure 4 Global Paroxysmal Supraventricular Tachycardia (PSVT) Market Share, By Type 2016
Figure 5 Global Paroxysmal Supraventricular Tachycardia (PSVT) Market Share, By Diagnosis 2016
Figure 6 Global Paroxysmal Supraventricular Tachycardia (PSVT) Market Share, By Treatment, 2016
Figure 7 Global Paroxysmal Supraventricular Tachycardia (PSVT) Market Share, By Region, 2016
Continued…
Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/5918 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.